Clinical Observation on Weining Granules Combined with Chemotherapy in the Treatment of Advanced Gastric Cancer

DENG Xin,LI Xuan,LIANG Jian
DOI: https://doi.org/10.3969/j.issn.1673-6575.2012.02.003
2012-01-01
Abstract:Objective To investigate the clinical efficacy of the Weining granules combined with chemotherapy in the treatment of advanced gastric cancer.Methods In a multicenter,randomized controlled clinical trial,80 patients with unresectable or postoperative recurrent gastric cancer were randomly assigned in a 1:1 ratio to receive chemotherapy alone(control group) or combined with the Weining granules(treatment group).After 3 courses of treatment,overall clinical efficacy,quality of life and safety profiles were assessed.Results The Weining granules given in combination with chemotherapy for 12 weeks in the treatment group were associated with improved symptoms from baseline(P0.05).The combination therapy significantly improved belching,anorexia and fatigue,compared with chemotherapy alone(P0.05).Solid tumors were significantly more likely to respond to the combination therapy than to the monotherapy(52.5% vs.25.0%,P0.05).Quality of life,physical function,role function,emotional function,social function,pain and overall health were improved to a significantly greater extent with the combination therapy than with chemotherapy alone(P0.05).Significant improvements in nausea,vomiting,appetite loss,and diarrhea from baseline were observed in patients receiving the Weining granules plus chemotherapy(P0.05),but not in those receiving chemotherapy alone(P0.05).No significant differences in safety parameters were found between the combination-therapy group and the monotherapy group,except that patients receiving the combination therapy were significantly more likely to experience grade III or higher toxicities.Conclusions Overall,the addition of the Weining granules to chemotherapy can result in improved clinical symptoms,enhanced quality of life,and reduced chemotherapy-induced toxicities in patients with advanced gastric cancer.No adverse event that is considered to be related to the granules is reported.Therefore,the Weining granule appears to be an effective and safe option for the treatment of advanced gastric cancer.
What problem does this paper attempt to address?